Financial Statements · Financial Reporting
Swixx Biopharma OÜ
Official identifier 12741121Record date 31 Dec 2025
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2025
- Period start
- 1 Jan 2025
- Submitted date
- 16 Jun 2026
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Bilanss, detailne | Assets | 1,642,627 |
| Bilanss, detailne | Cash and cash equivalents | 165,631 |
| Bilanss, detailne | Current assets | 1,621,942 |
| Bilanss, detailne | Current liabilities | 608,989 |
| Bilanss, detailne | Equity | 1,033,638 |
| Bilanss, detailne | Share capital at nominal value | 2,500 |
| Bilanss, detailne | Non-current assets | 20,685 |
| Bilanss, detailne | Retained earnings (loss) from previous periods | 685,148 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -12,887 |
| Income statement scheme 1 | Labour costs | -2,672,031 |
| Income statement scheme 1 | Revenue | 4,406,198 |
| Income statement scheme 1 | Annual period profit / loss | 345,740 |
| Income statement scheme 1 | Operating profit (loss) | 345,663 |
| Income statement scheme 1 | Profit (loss) before income tax | 345,740 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 685,148 |
| Note: Labour costs | Employees | 27 |
| Note: Labour costs | Labour costs | 2,672,031 |
Linked company
Company: Swixx Biopharma OÜ